<?xml version="1.0" encoding="utf-8" standalone="yes"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>Regulations on FinanClub</title>
    <link>https://finan.club/tags/regulations/</link>
    <description>Recent content in Regulations on FinanClub</description>
    <generator>Hugo -- gohugo.io</generator>
    <language>en-us</language>
    <lastBuildDate>Tue, 23 Jan 2024 09:05:47 +0000</lastBuildDate><atom:link href="https://finan.club/tags/regulations/index.xml" rel="self" type="application/rss+xml" />
    <item>
      <title>MRK</title>
      <link>https://finan.club/us/mrk/</link>
      <pubDate>Tue, 23 Jan 2024 09:05:47 +0000</pubDate>
      
      <guid>https://finan.club/us/mrk/</guid>
      <description>score:93
Chances: Merck &amp;amp; Co., Inc. continues to deliver positive news with the FDA approval of Keytruda for cervical cancer treatment. The Pharmaceutical segment of the company includes human health pharmaceutical and vaccine products, which positions it well in the current healthcare market.</description>
    </item>
    
  </channel>
</rss>
